Awardee research areas underline breadth of field and comprehensive approach to studying lupus.
CEO Sandra C. Raymond responds to announcement of Phase III trial results of anifrolumab.
Exagen Diagnostics and CareFirst BlueCross have come together for the new lupus diagnostic test.
Grant awardees focus on moving research forward in two critical areas, childhood lupus and kidney damage
The LFA, in partnership with NIAD, will co-fund a study researching potential new lupus treatments.
A diagnostic test developed through research supported by the Foundation has found to be a reliable measure of lupus disease activity.
Foundation’s bridge-funding supported Dr. Jill Buyon’s lab at NYU-Langone to continue study on pregnancy and lupus
A recently published study concludes that lupus is among the leading causes of death for women in the U.S.